The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Oliver G. Ottmann

Medizinische Klinik II

Department of Hematology and Oncology

Goethe University




Name/email consistency: high



  • Medizinische Klinik II, Department of Hematology and Oncology, Goethe University, Frankfurt, Germany. 1998 - 2009
  • Department of Hematology, University Hospital of Frankfürt, Germany. 2007
  • Universitatsklinik Frankfurt, Medizinische Klinik III, Theodor-Stern-Kai 7, Frankfurt D-60590, Germany. 2005
  • Medizinische Klinik III, Abteilung für Hämatologie und Onkologie, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, Germany. 2002


  1. First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults. Ottmann, O.G., Pfeifer, H. Curr. Opin. Oncol (2009) [Pubmed]
  2. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Ottmann, O.G., Pfeifer, H. Hematology. Am. Soc. Hematol. Educ. Program (2009) [Pubmed]
  3. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Ottmann, O.G., Wassmann, B., Pfeifer, H., Giagounidis, A., Stelljes, M., Dührsen, U., Schmalzing, M., Wunderle, L., Binckebanck, A., Hoelzer, D. Cancer (2007) [Pubmed]
  4. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia. Ottmann, O.G., Bug, G., Krauter, J. Semin. Hematol. (2007) [Pubmed]
  5. Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study. Ottmann, O., Dombret, H., Martinelli, G., Simonsson, B., Guilhot, F., Larson, R.A., Rege-Cambrin, G., Radich, J., Hochhaus, A., Apanovitch, A.M., Gollerkeri, A., Coutre, S. Blood (2007) [Pubmed]
  6. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Ottmann, O.G., Wassmann, B. Hematology. Am. Soc. Hematol. Educ. Program (2005) [Pubmed]
  7. Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphisms. Brück, P., Wassmann, B., Lopez, E.R., Hoelzer, D., Ottmann, O.G. Leuk. Res. (2004) [Pubmed]
  8. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Ottmann, O.G., Druker, B.J., Sawyers, C.L., Goldman, J.M., Reiffers, J., Silver, R.T., Tura, S., Fischer, T., Deininger, M.W., Schiffer, C.A., Baccarani, M., Gratwohl, A., Hochhaus, A., Hoelzer, D., Fernandes-Reese, S., Gathmann, I., Capdeville, R., O'Brien, S.G. Blood (2002) [Pubmed]
  9. Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving concepts. Ottmann, O.G., Wassmann, B. Best. Pract. Res. Clin. Haematol (2002) [Pubmed]
  10. Growth factors in the treatment of acute lymphoblastic leukemia. Ottmann, O.G., Hoelzer, D. Leuk. Res. (1998) [Pubmed]
WikiGenes - Universities